Case Study: CSL Behring improves patient adoption and retention with BrightInsight

CSL Behring launches Hizentra app in 6 months with BrightInsight

CSL Behring, a global biotherapeutics leader, needed a foundational platform to build and scale its digital health offerings for patients with rare diseases. Their challenge was to improve treatment experiences while ensuring compliance with global regulatory requirements. They selected the BrightInsight platform to develop and host these digital health solutions.

BrightInsight implemented its unified platform, enabling the rapid development and launch of the Hizentra app in just six months. The solution achieved significant results, with the app being quickly adopted by thousands of users and reaching 20% of the brand's U.S. patient population without dedicated marketing. BrightInsight provided CSL Behring with critical insights to improve patient care.

CSL Behring